Journalists Explain Medicaid Work Requirements and Hospital Price Transparency
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Southern Bureau
Ñî¹óåú´«Ã½Ò•îl Health News tells the stories of Georgia and the rest of the South.
881-900 of 1,228 results
-
-
Hospital Financial Decisions Play a Role in the Critical Shortage of Pediatric Beds for RSV Patients
Yes, the U.S. is experiencing an unusual spate of childhood RSV infections. But the critical shortage of hospital beds to treat ailing children stems from structural problems in pediatric care that have been brewing for years.
By Liz Szabo -
More States to Consider Extending Postpartum Medicaid Coverage Beyond Two Months
Fifteen states haven’t moved to extend Medicaid coverage for new moms beyond the minimum of 60 days after birth. But at least four of those holdout states — Montana, Wyoming, Missouri, and Mississippi — are expected to consider proposals to extend coverage in their upcoming legislative sessions.
By Matt Volz -
Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.
The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.
By Hannah Recht -
Florida Leaders Misrepresented Research Before Ban on Gender-Affirming Care
The Florida policy backed by Gov. Ron DeSantis relies on one key statistic that many experts question.
-
Much of the CDC Is Working Remotely. That Could Make Changing the Agency Difficult.
Like many U.S. workplaces, the Centers for Disease Control and Prevention went remote during the pandemic. Most of the agency’s staff members haven’t returned to the office full time, raising concerns about the CDC’s ability to reform itself after recent stumbles.
-
Journalists Discuss Medicaid Rules, Opioid Settlement Funds, and the Public Health Workforce
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.
Private equity-backed Headlands Research heralded its covid-19 vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.
-
Her Apartment Might Have Put Her Son’s Health at Risk. But ‘I Have Nowhere Else to Go.’
The United States is suffering from a severe shortage of affordable housing. But elected officials have done little to fix a problem that puts many Americans at greater risk for sickness and shortens lives.
By Renuka Rayasam and Fred Clasen-Kelly -
Racial Disparities in Lung Cancer Start With Research
Improving lung cancer outcomes in Black communities will take more than lowering the screening age, experts say. Disparities are present in everything from the studies that inform when people should get checked to the availability of care in rural areas.
-
An Unexplained Injury Discovered After Eye Surgery. What Should Happen Next?
Some doctors and medical practices voluntarily give rebates on a bill if an injury occurs during a procedure, while others will not, an expert says. Here’s how patients can respond.
-
When Malpractice Occurs at Community Health Centers, Taxpayers Pay
Federally funded clinics and their doctors are protected against lawsuits by federal law, with taxpayers footing the bill. The health centers say that allows them to better serve their low-income patients, but lawyers say the system handcuffs consumers with a cumbersome legal process and makes it harder for the public to see problems.
By Phil Galewitz and Bram Sable-Smith -
‘An Arm and a Leg’: When Insurance Won’t Pay, Abortion Assistance Funds Step In
Privacy concerns and coverage limits have long made insurance an unreliable option for abortion access. For decades, abortion funds have been stepping in to help people pay for what they see as essential health care.
-
Treating Long Covid Is Rife With Guesswork
With a dearth of evidence on effective treatments for long covid, patients and doctors in 400 clinics around the country still rely on trial and error.
-
Schools, Sheriffs, and Syringes: State Plans Vary for Spending $26B in Opioid Settlement Funds
The cash represents an unprecedented opportunity to derail the opioid epidemic, but with countless groups advocating for their share of the pie, the impact could depend heavily on geography and politics.
-
Patient Mistrust and Poor Access Hamper Federal Efforts to Overhaul Family Planning
For decades, many women of color, particularly those with low incomes, had little control over their family planning care. Now, a White House effort aims to give patients more choices as abortion care evaporates, but patients remain wary of providers.
-
As STDs Proliferate, Companies Rush to Market At-Home Test Kits. But Are They Reliable?
The popularity of at-home covid tests has amplified calls from public health researchers and diagnostic companies to make home testing similarly routine for sexually transmitted diseases. But FDA guidelines are lagging.
By Liz Szabo -
Path Cleared for Georgia to Launch Work Requirements for Medicaid
Federal officials have apparently stopped fighting Georgia’s plan for a limited Medicaid expansion that includes work requirements. The plan, a key policy of Republican Gov. Brian Kemp’s, would cover a much smaller portion of the population: those who can work or volunteer 80 hours a month.
By Andy Miller and Sam Whitehead -
How Banks and Private Equity Cash In When Patients Can’t Pay Their Medical Bills
Hospitals strike deals with financing companies, generating profits for lenders, and more debt for patients.
By Noam N. Levey and Aneri Pattani -
How Optimism Can Close the Medicaid Coverage Gap
Low-income residents in states that haven’t expanded Medicaid are in a tough spot: They don’t qualify for the subsidies that people with slightly higher incomes get to buy marketplace plans because of a glitch in the federal health law. But a court decision last year makes it easier for them to make good-faith estimates of a pay increase, and there is no financial penalty if they don’t hit that figure.
By Phil Galewitz and Daniel Chang